Transient tachypnoea of newborn. Transient tachypnoea of newborn
Conditions
Interventions
Intervention 1: Intervention group: Salbutamol was administered in the intervention group. The solution was administered as an inhaler and through a nebulizer jet with an oxygen flow rate of 6-5 liter
Treatment - Drugs
Placebo
Intervention group: Salbutamol was administered in the intervention group. The solution was administered as an inhaler and through a nebulizer jet with an oxygen flow rate of 6-5 liters per minute.The
Control group: Normal saline (placebo) was administered in the control group. The solution was administered as an inhaler and through a nebulizer jet with an oxygen flow rate of 6-5 liters per minute.
Sponsors
Vice Chancellor research of Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 28 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Rawlings and Smith's criteria include: 1) Tachypnea (RR> 60) during the first 6 hours of birth 2) Continuity of tachypnea for at least 12 hours 3) The CXR view consists of at least one of the following: elevation of the central vessels of the lung, increasing the thickness of the lobes between the lobes due to fluid accumulation, congestion of the navel of both lungs, airy lung, ie flattening of the diaphragm or enlargement of the anterior posterior chest or both Exclusion criteria: 1) Neonates with congenital anomalies 2) Proven systemic infection (positive blood culture) 3) Meconium aspiration 4) Respiratory distress syndrome (based on the graph) 5) Intrauterine growth retardation 6) history of fetal distress, pneumonitis, congenital heart disease, DIC, multi organ failure, hypocalcemia, hypoglycemia and polycythemia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Breathing rate. Timepoint: 30 min, 1 and 4 h after Intervention. Method of measurement: Number of breaths per minute.;Heart beat. Timepoint: 30 min, 1 and 4 h after Intervention. Method of measurement: heart beat per minute.;Fraction of inspired oxygen. Timepoint: 30 min, 1 and 4 h after Intervention. Method of measurement: FIO2 %.;O2 saturation. Timepoint: 30 min, 1 and 4 h after Intervention. Method of measurement: Pulse oximetry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Glucose. Timepoint: 12 h after intervention. Method of measurement: blood test.;Potassium. Timepoint: 12 h after intervention. Method of measurement: blood test.;Arterial blood gas. Timepoint: 12 h after intervention. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Arash Malakian
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed